Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Shire Development, LLC v. Mylan Pharmaceuticals Inc., No. 17-2268 (Fed. Cir. Apr. 6, 2018)

Affirmed
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 17-2268
Decided
April 6, 2018
Judge
Per curiam (Rule 36)
Document
Rule 36 Judgment
Length
2 pages

NOTE: This disposition is nonprecedential. United States Court of Appeals

for the Federal Circuit SHIRE DEVELOPMENT, LLC, SHIRE

PHARMACEUTICAL DEVELOPMENT, INC.,

COSMO TECHNOLOGIES LIMITED, NOGRA

PHARMA LIMITED,

Plaintiffs-Appellants

v.

MYLAN PHARMACEUTICALS INC., MYLAN, INC.,

Defendants-Appellees

2017-2268

Appeal from the United States District Court for the Middle District of Florida in No. 8:12-cv-01190-CEH-AEP, Judge Charlene Edwards Honeywell.

JUDGMENT

ELIZABETH MURPHY, Haug Partners LLP, New York, NY, argued for plaintiffs-appellants. Also represented by EDGAR HAUG, ERIKA SELLI.

DEEPRO MUKERJEE, Alston & Bird LLP, New York, NY, argued for defendants-appellees. Also represented by LANCE SODERSTROM.

2THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT April 6, 2018 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Shire Development, LLC v. Mylan Pharmaceuticals Inc., No. 17-2268 (Fed. Cir. Apr. 6, 2018).

govinfo ID
USCOURTS-ca13-17-02268-0
Permalink
https://patentcasewatch.com/opinions/USCOURTS-ca13-17-02268-0

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.